uniQure (QURE) Other Non Operating Income (2016 - 2026)
uniQure (QURE) recorded quarterly Other Non Operating Income of -$2.3 million in Q1 2026, up 84.15% quarter-over-quarter from -$14.5 million in Q4 2025, and down 131.99% on a YoY basis from $7.2 million in Q1 2025.
uniQure (QURE) Other Non Operating Income (2016 - 2026) Analysis & Trends
uniQure's Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$2.3 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 131.99% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at -$5.4 million (down 144.52% YoY), while the FY2025 annual figure was $10.9 million, up 203.79% from the prior year.
- Other Non Operating Income was -$2.3 million for Q1 2026 at uniQure, up from -$14.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $22.6 million in Q4 2022 to a low of -$15.9 million in Q4 2024.
- Historically, Other Non Operating Income has averaged $2.7 million across 5 years, with a median of $186000.0 in 2023.
- Biggest YoY gain for Other Non Operating Income was 3966.67% in 2024; the steepest drop was 13605.93% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $22.6 million in 2022, then tumbled by 99.48% to $118000.0 in 2023, then plunged by 13605.93% to -$15.9 million in 2024, then increased by 9.16% to -$14.5 million in 2025, then jumped by 84.15% to -$2.3 million in 2026.
- The last three Other Non Operating Income figures came in at -$2.3 million (Q1 2026), -$14.5 million (Q4 2025), and -$7.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.29 Mn |
| Dec 31, 2025 | -14.48 Mn |
| Sep 30, 2025 | -7.22 Mn |
| Jun 30, 2025 | 18.64 Mn |
| Mar 31, 2025 | 7.17 Mn |
| Dec 31, 2024 | -15.94 Mn |
| Sep 30, 2024 | 7.56 Mn |
| Jun 30, 2024 | -989,000.00 |
| Mar 31, 2024 | -1.15 Mn |
| Dec 31, 2023 | 118,000.00 |
| Sep 30, 2023 | 186,000.00 |
| Jun 30, 2023 | 374,000.00 |
| Mar 31, 2023 | -2.37 Mn |
| Dec 31, 2022 | 22.60 Mn |
| Sep 30, 2022 | 14.36 Mn |
| Jun 30, 2022 | 19.40 Mn |
| Mar 31, 2022 | 692,000.00 |
| Dec 31, 2021 | 8.02 Mn |
| Sep 30, 2021 | 10.44 Mn |
| Jun 30, 2021 | 6.58 Mn |